Conference Reports for NATAP
The Liver Meeting
San Francisco
November 2018
Back
 
GLECAPREVIR/PIBRENTASVIR ADMINISTERED FOR 8 WEEKS RESULTS IN EXCELLENT EFFECTIVENESS AND SAFETY: A REAL-LIFE STUDY ON 639 ITALIAN HCV PATIENTS FROM THE NAVIGATOR LOMBARDIA NETWORK
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF